Mitsuyo Kinjo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mitsuyo Kinjo has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Yano
30 shared publications- Masaki Itagane
Rheumatology, Okinawa Chubu Hospital, Uruma, Okinawa, Japan
6 shared publications Hiroyuki Teruya
Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan
4 shared publications- Hiroyuki Yano
Institute of Food Research, National Agriculture and Food Research Organization, Tsukuba 305-8642, Japan
3 shared publications Masaki Itagane
Department of Medicine, Okinawa Chubu Hospital, Okinawa, Japan
3 shared publicationsHitoshi Miyasato
Department of Internal Medicine, Okinawa Chubu Hospital, Okinawa, Japan
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11) , 1626-1637
Multicenter Clinical Comparison Between Anti‐ NXP2 and Anti‐ TIF1 ‐γ Antibody‐Positive Myositis, and Analysis of the Clinical Significance of Anti‐ NXP2 Antibody Titers in Idiopathic Inflammatory Myopathies
We aimed to measure anti‐nuclear matrix protein 2 antibody (anti‐NXP2) titers in patients with anti‐NXP2‐positive idiopathic inflammatory myopathies, investigate whether these titers are associated with clinical manifestations, malignancy risk, and treatment response, and compare the clinical and serological features between anti‐NXP2‐positive and anti‐transcriptional intermediary factor 1‐γ antibody (anti‐TIF1‐γ)‐positive dermatomyositis in order to identify practical indicators for differentiating the two subsets. We established a newly optimized in‐house enzyme‐linked immunosorbent assay for the quantitative measurement of anti‐NXP2. After excluding two of the 34 initially identified patients with anti‐NXP2 antibody reactivity, we used the assay to analyse sera from 32 patients with anti‐NXP2‐positive idiopathic inflammatory myopathy. Clinical correlations between anti‐NXP2 titers and inflammatory indices, cardiothoracic ratio, malignancy status, and longitudinal changes after immunosuppressive therapy were examined. We developed a novel clinical scoring system to differentiate between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. The anti‐TIF1‐γ‐positive patients showed a higher frequency of classic dermatomyositis skin manifestations, whereas the anti‐NXP2‐positive patients had significantly higher creatine kinase, aldolase, and lactate dehydrogenase levels, indicating more prominent muscle involvement. Anti‐NXP2 titers correlated with erythrocyte sedimentation rate and cardiothoracic ratio and were significantly higher in patients with malignancy in the anti‐NXP2‐positive idiopathic inflammatory myopathy patients. Longitudinal analyses demonstrated declines in antibody titers after immunosuppressive treatment. Our scoring system, incorporating age at onset, Gottron's sign, creatine kinase, lactate dehydrogenase, and malignancy status, highly accurately distinguished between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. Anti‐NXP2 titers reflect systemic inflammation, cardiac involvement, and malignancy risk in anti‐NXP2‐positive idiopathic inflammatory myopathy. The observed decline in anti‐NXP2 titers after therapy suggests the potential utility of these titers as biomarkers for longitudinal disease assessment and stratifying malignancy risk.
- 16 September 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11) , 1626-1637
Open AccessMulticenter Clinical Comparison Between Anti‐ NXP2 and Anti‐ TIF1 ‐γ Antibody‐Positive Myositis, and Analysis of the Clinical Significance of Anti‐ NXP2 Antibody Titers in Idiopathic Inflammatory Myopathies
We aimed to measure anti‐nuclear matrix protein 2 antibody (anti‐NXP2) titers in patients with anti‐NXP2‐positive idiopathic inflammatory myopathies, investigate whether these titers are associated with clinical manifestations, malignancy risk, and treatment response, and compare the clinical and serological features between anti‐NXP2‐positive and anti‐transcriptional intermediary factor 1‐γ antibody (anti‐TIF1‐γ)‐positive dermatomyositis in order to identify practical indicators for differentiating the two subsets. We established a newly optimized in‐house enzyme‐linked immunosorbent assay for the quantitative measurement of anti‐NXP2. After excluding two of the 34 initially identified patients with anti‐NXP2 antibody reactivity, we used the assay to analyse sera from 32 patients with anti‐NXP2‐positive idiopathic inflammatory myopathy. Clinical correlations between anti‐NXP2 titers and inflammatory indices, cardiothoracic ratio, malignancy status, and longitudinal changes after immunosuppressive therapy were examined. We developed a novel clinical scoring system to differentiate between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. The anti‐TIF1‐γ‐positive patients showed a higher frequency of classic dermatomyositis skin manifestations, whereas the anti‐NXP2‐positive patients had significantly higher creatine kinase, aldolase, and lactate dehydrogenase levels, indicating more prominent muscle involvement. Anti‐NXP2 titers correlated with erythrocyte sedimentation rate and cardiothoracic ratio and were significantly higher in patients with malignancy in the anti‐NXP2‐positive idiopathic inflammatory myopathy patients. Longitudinal analyses demonstrated declines in antibody titers after immunosuppressive treatment. Our scoring system, incorporating age at onset, Gottron's sign, creatine kinase, lactate dehydrogenase, and malignancy status, highly accurately distinguished between anti‐NXP2‐positive and anti‐TIF1‐γ‐positive myositis. Anti‐NXP2 titers reflect systemic inflammation, cardiac involvement, and malignancy risk in anti‐NXP2‐positive idiopathic inflammatory myopathy. The observed decline in anti‐NXP2 titers after therapy suggests the potential utility of these titers as biomarkers for longitudinal disease assessment and stratifying malignancy risk.
- 20 July 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 152
A Woman with Progressive Skin Ulceration
- 20 July 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 152
A Woman with Progressive Skin Ulceration
- Open Access
- 22 June 2026
- Published by Wiley in ACR Open Rheumatology
- Vol. 8 (6) , e90098
Clinical Images: Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly syndrome presenting as bilateral adrenal hemorrhage
- 22 June 2026
- Published by Wiley in ACR Open Rheumatology
- Vol. 8 (6) , e90098
Open AccessClinical Images: Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly syndrome presenting as bilateral adrenal hemorrhage
- 24 February 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (3) , 179-187
Man with impaired consciousness and blue tongue
- 24 February 2026
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (3) , 179-187
Man with impaired consciousness and blue tongue
- 21 May 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (5) , e265943
Osmotic demyelination syndrome in an alcoholic patient
- 21 May 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (5) , e265943
Osmotic demyelination syndrome in an alcoholic patient
- 29 April 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (4) , e262963
Recurrent Ludwig’s angina mimic
- 29 April 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (4) , e262963
Recurrent Ludwig’s angina mimic
- 12 April 2025
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (9) , e175-e176
An Uncommon Cause of Unilateral Paroxysmal Headache
- 12 April 2025
- Published by Elsevier in The American Journal of Medicine
- Vol. 138 (9) , e175-e176
An Uncommon Cause of Unilateral Paroxysmal Headache
- 2 April 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (4) , e264753
Pneumococcal meningitis presenting as stroke: a diagnostic challenge
- 2 April 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (4) , e264753
Pneumococcal meningitis presenting as stroke: a diagnostic challenge
- 21 January 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 134, 130-131
A man with trismus and decubitus ulcers
- 21 January 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 134, 130-131
A man with trismus and decubitus ulcers
- Open Access
- 15 December 2024
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 63 (24) , 3401
Staphylococcus aureus Lip Infection
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 15 December 2024
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 63 (24) , 3401
Open AccessStaphylococcus aureus Lip Infection
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.